1 day ago GILEAD SCIENCES, INC. GILD. Delayed Quote. Delayed - 04/21 04:00:00
Gilead Sciences. stock was originally listed at a price of $1.20 in Dec 31, 1997. If you had invested in Gilead Sciences stock at $1.20, your return over the last 23 years would have been 5,495.82%, for an annualized return of 19.12%.
The rise to weekly highs of $66.91 on Wednesday, Apr 21 increased the stock’s daily price by 3.34%. Gilead Sciences stock forecast & analyst price target predictions based on 17 analysts offering 12-months price targets for GILD in the last 3 months. 2021-04-23 · Gilead Sciences (GILD) Stock Moves -0.53%: What You Should Know Gilead Sciences (GILD) closed at $64.08 in the latest trading session, marking a -0.53% move from the prior day. 1 month ago - Zacks Investment Research Instrument NameGilead Sciences IncInstrument ExchangeNASDAQ:Instrument SymbolGILD-Q. Gilead Sciences Inc. 65.95 USD. Today's Change. unch.
Since then, GILD shares have decreased by 9.3% and is now trading at $66.87. View which stocks have been most impacted by COVID-19. 2020-05-08 · Is Gilead Sciences Stock a Buy? But given what little we actually know about remdesivir, the jump in Gilead's share price seems overdone. Image source: Getty Images. This price target is based on 23 analysts offering 12 month price targets for Gilead Sciences in the last 3 months. The average price target is $97.92, with a high forecast of $625.00 and a low forecast of $61.00. The average price target represents a 46.43% upside from the last price of $66.87.
View real-time stock prices and stock quotes for a full financial overview.
2021-04-16 · Get the latest Gilead Sciences (GILD) stock price quote with real-time news, financials, charts and other important investing information.
102 rows GILEAD SCIENCES, INC. analysts consensus, targets, ratings and recommendations | Nasdaq: GILD | Nasdaq. Evolution of the average Target Price on GILEAD SCIENCES, INC. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ 456 rows Gilead Sciences stock forecast & analyst price target predictions based on 17 analysts offering 12-months price targets for GILD in the last 3 months. 2020-12-23 Gilead Stock Price.
Stock quote and company snapshot for GILEAD SCIENCES INC (GILD), including profile, stock chart, recent news and events, analyst opinions, and research
GILD has a higher market value than 97.02% of US stocks; more precisely, its current market capitalization is $82,872,318,638. GILD's current price/earnings ratio is 673.76, which is higher than 98.74% of US stocks with positive earnings. In terms of volatility of its share price, GILD is more volatile than merely 6.06% of stocks we're observing. Gilead's share price is up 16% from its March 23 level, and 20% above its price at February 21, pre the COVID-19-induced dip in the wider market. Gilead stock surged significantly after my buy recommendation in December as a consequence of Remdesivir's potential to treat COVID-19.
The Gilead Sciences 52-week low stock price is 56.56, which is 14% below the current share price.
Veronicka vikman
According to . 14 Wall Street analysts that have issued a 1 year GILD price target, the average GILD price target is $76.93, with the highest GILD stock price forecast at $88.00 and the lowest GILD stock price forecast at $61.00. 355 rows Gilead Sciences' stock was trading at $73.70 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GILD shares have decreased by 9.3% and is now trading at $66.87.
View the latest Gilead Sciences Inc. (GILD) stock price, news, historical charts, analyst ratings and financial information from WSJ.
GILD: Get the latest Gilead Sciences stock price and detailed information including GILD news, historical charts and realtime prices. 23 brokerages have issued 12-month price targets for Gilead Sciences' shares. Their forecasts range from $61.00 to $625.00.
Studio musik jakarta
bokföra swish avgift
utbildningar pa distans
betala in reavinstskatt
vad kostar ett barn till 18 år
GILD - Gilead Sciences Inc. Chart, Stock Price » 65.48: Last as of 4 Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
The average price target represents a 46.43% upside from the last price of $66.87. Gilead Stock Price As the chart below shows, Gilead's share dropped from the highs around $20 in 2015 to close to $50, but have recovered in 2020 as Remdesivir is gradually becoming a household name. Gilead Sciences stock price prediction is an act of determining the future value of Gilead Sciences shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Gilead Sciences stock future price could yield a significant profit.
Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
That’s a $98 billion market capitalization on sales of $22.5 billion. GILEAD SCIENCES, INC. analysts consensus, targets, ratings and recommendations | Nasdaq: GILD | Nasdaq. Evolution of the average Target Price on GILEAD SCIENCES, INC. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ 2020-04-17 2020-07-01 2020-03-16 2020-12-23 1 day ago 2020-06-05 2021-04-12 2021-02-01 2021-01-23 2020-04-09 1 day ago 2021-03-18 Gilead retains 20-year remdesivir patents in more than 70 countries. Gilead has also been accused of price-gouging on other medications developed with public funding, including AIDS PrEP drug Tenofovir and hepatitis C drug sofosbuvir as well as Remdesivir.
Analysts expect Gilead Sciences will release earnings per share of $2.08. Follow Gilead Sciences stock price in real-time Gilead Sciences Inc (NASDAQ:GILD) Gilead Sciences Inc. 66.77. Delayed Data. As of Apr 21.